UroToday
UroToday is the prostate, bladder, and kidney cancer feed, including PSMA and radioligand news.
Overview
UroToday is the daily feed for prostate, bladder and kidney cancer, holding genitourinary oncology abstracts, conference coverage and expert video, including PSMA and radioligand news. It is published by Digital Science Press and is free with registration. Its conference coverage of ASCO GU, EAU, AUA and the PSMA conference is exhaustive, which makes it the quickest way to follow a genitourinary meeting without attending. On Nuclide it is listed as a source with the tags source and news, read for the genitourinary cancers and for radioligand therapy news.
Similar pages
not linked directly; found by shared links- TrialA Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metasta
Shares Renal cell carcinoma, Prostate cancer.
- TermOligometastatic disease
Shares Renal cell carcinoma, Prostate cancer.
- CompanyPfizer (incl. Seagen)
Shares Renal cell carcinoma, Prostate cancer.
- InstitutionANZUP Cancer Trials Group
Shares Renal cell carcinoma, Prostate cancer.
- TermBone metastases and skeletal-related events
Shares Renal cell carcinoma, Prostate cancer.
- AgentPembrolizumab
Shares Renal cell carcinoma, Prostate cancer.
- CompanyTelix Pharmaceuticals
Shares Renal cell carcinoma, Prostate cancer.